These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 21164126)

  • 1. Intracranial atherosclerosis: current concepts.
    Arenillas JF
    Stroke; 2011 Jan; 42(1 Suppl):S20-3. PubMed ID: 21164126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of SAMMPRIS on the future of intracranial atherosclerotic disease management: polling results from the ICAD symposium at the International Stroke Conference.
    Zaidat OO; Castonguay AC; Nguyen TN; Becker KJ; Derdeyn CP; Nelson PK; Amarenco P; Brott TG
    J Neurointerv Surg; 2014 Apr; 6(3):225-30. PubMed ID: 23563478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results.
    Qureshi AI; Feldmann E; Gomez CR; Johnston SC; Kasner SE; Quick DC; Rasmussen PA; Suri MF; Taylor RA; Zaidat OO
    J Neuroimaging; 2009 Oct; 19 Suppl 1():1S-10S. PubMed ID: 19807850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular management of intracranial atherosclerosis.
    Teleb MS; Asif K; Castonguay AC; Zaidat OO
    Neurosurg Clin N Am; 2014 Jul; 25(3):593-605. PubMed ID: 24994093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, diagnosis and management of intracranial atherosclerotic disease.
    Jeng JS; Tang SC; Liu HM
    Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1423-32. PubMed ID: 20936929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Systemic Atherosclerosis Burdens and Overlapping Stroke Etiologies and Their Associations With Long-term Vascular Prognosis in Stroke With Intracranial Atherosclerotic Disease.
    Hoshino T; Sissani L; Labreuche J; Ducrocq G; Lavallée PC; Meseguer E; Guidoux C; Cabrejo L; Hobeanu C; Gongora-Rivera F; Touboul PJ; Steg PG; Amarenco P;
    JAMA Neurol; 2018 Feb; 75(2):203-211. PubMed ID: 29279888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial Large and Medium Artery Atherosclerotic Disease and Stroke.
    Al Kasab S; Derdeyn CP; Guerrero WR; Limaye K; Shaban A; Adams HP
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1723-1732. PubMed ID: 29602616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and prognosis of asymptomatic intracranial atherosclerosis in a community-based population: Results based on high-resolution magnetic resonance imaging.
    Li S; Tang M; Zhang D; Han F; Zhou L; Yao M; Li M; Cui L; Zhang S; Peng B; Jin Z; Zhu Y; Ni J
    Eur J Neurol; 2023 Dec; 30(12):3761-3771. PubMed ID: 37738517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological signatures of asymptomatic extra- and intracranial atherosclerosis: the Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) study.
    López-Cancio E; Galán A; Dorado L; Jiménez M; Hernández M; Millán M; Reverté S; Suñol A; Barallat J; Massuet A; Alzamora MT; Dávalos A; Arenillas JF
    Stroke; 2012 Oct; 43(10):2712-9. PubMed ID: 22798326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of early Recurrence in Intracranial Atherosclerotic Disease (MyRIAD): Rationale and design.
    Liebeskind DS; Prabhakaran S; Azhar N; Feldmann E; Campo-Bustillo I; Sangha R; Koch S; Rundek T; Ostergren L; Chimowitz MI; Romano JG;
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105051. PubMed ID: 32912558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard of practice: endovascular treatment of intracranial atherosclerosis.
    Hussain MS; Fraser JF; Abruzzo T; Blackham KA; Bulsara KR; Derdeyn CP; Gandhi CD; Hirsch JA; Hsu DP; Jayaraman MV; Meyers PM; Narayanan S; Prestigiacomo CJ; Rasmussen PA;
    J Neurointerv Surg; 2012 Nov; 4(6):397-406. PubMed ID: 22705876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and imaging of intracranial atherosclerotic stenosis: current perspectives and future directions.
    van den Wijngaard IR; Holswilder G; van Walderveen MA; Algra A; Wermer MJ; Zaidat OO; Boiten J
    Brain Behav; 2016 Nov; 6(11):e00536. PubMed ID: 27843693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lesion stability characteristics outperform degree of stenosis in predicting outcomes following stenting for symptomatic intracranial atherosclerosis.
    Alexander MD; Cooke DL; Meyers PM; Amans MR; Dowd CF; Halbach VV; Higashida RT; Hetts SW
    J Neurointerv Surg; 2016 Jan; 8(1):19-23. PubMed ID: 25416828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2023 Taiwan Stroke Society Guidelines for the management of patients with intracranial atherosclerotic disease.
    Lin CJ; Chung CP; Liao NC; Chen PL; Chi NF; Lai YJ; Tang CW; Wu CH; Chang FC; Luo CB; Fay LY; Lin CF; Chou CH; Lee TH; Lee JT; Jeng JS; Lee IH;
    J Chin Med Assoc; 2023 Aug; 86(8):697-714. PubMed ID: 37341526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial atherosclerosis: correlation between in-vivo 3T high resolution MRI and pathology.
    Turan TN; Rumboldt Z; Granholm AC; Columbo L; Welsh CT; Lopes-Virella MF; Spampinato MV; Brown TR
    Atherosclerosis; 2014 Dec; 237(2):460-3. PubMed ID: 25463074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encephaloduroarteriosynangiosis Averts Stroke in Atherosclerotic Patients With Border-Zone Infarct: Post Hoc Analysis From a Performance Criterion Phase II Trial.
    Quintero-Consuegra MD; Toscano JF; Babadjouni R; Nisson P; Kayyali MN; Chang D; Almallouhi E; Saver JL; Gonzalez NR
    Neurosurgery; 2021 Mar; 88(4):E312-E318. PubMed ID: 33469657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging and clinical predictors of unfavorable outcome in medically treated symptomatic intracranial atherosclerotic disease.
    Kate M; Sylaja PN; Kesavadas C; Thomas B
    J Stroke Cerebrovasc Dis; 2014; 23(5):973-8. PubMed ID: 24119624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and determinants of intracranial atherosclerotic stroke in urban Pakistan.
    Kamal AK; Rasheed A; Mehmood K; Murtaza M; Zaidi M; Khan M; Shah N; Samuel M; Ahmed B; Raza E; Ahmed N; Ara J; Ahsan T; Munir SM; Ali S; Maki KU; Ahmed MM; Memon AR; Saleheen D
    J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2174-2182. PubMed ID: 25088165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High resolution MRI difference between moyamoya disease and intracranial atherosclerosis.
    Kim YJ; Lee DH; Kwon JY; Kang DW; Suh DC; Kim JS; Kwon SU
    Eur J Neurol; 2013 Sep; 20(9):1311-8. PubMed ID: 23789981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update in the treatment of intracranial atherosclerotic disease.
    Barnard ZR; Alexander MJ
    Stroke Vasc Neurol; 2020; 5(1):59-64. PubMed ID: 32411409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.